Early ablation leads to better outcome in patients<55 years with persistent atrial fibrillation

Nico Erhard1, Fabian Bahlke2, Bruno Neuner3

  • 1Department of Electrophysiology, German Heart Center Munich, Technical University of Munich, Lazarettstraße 36, 80636, Munich, Germany. nico.erhard@gmail.com.

Scientific Reports
|October 25, 2024
PubMed

Insights

Optimal timing for catheter ablation of atrial fibrillation (AF) is crucial. Early ablation (≤12 months) in patients under 55 with persistent AF significantly reduces arrhythmia recurrence compared to delayed procedures.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Optimal timing for catheter ablation of atrial fibrillation (AF) is a critical clinical question.
  • Limited data exists on the Diagnosis-to-Ablation Time (DAT) in younger patients (<55 years) with persistent AF.

Purpose of the Study:

  • To analyze the temporal relationship between initial AF diagnosis and catheter ablation timing in patients ≤55 years with persistent AF.
  • To assess the impact of DAT on arrhythmia recurrence after pulmonary vein isolation using high-power short-duration (HPSD) radiofrequency ablation.

Main Methods:

  • Retrospective single-center study of 101 patients (≤55 years) with persistent AF undergoing first-time catheter ablation.
  • Patients divided into early DAT (≤12 months) and late DAT (>12 months) groups.
  • Pulmonary vein isolation performed using HPSD radiofrequency ablation.

Main Results:

  • Early DAT (≤12 months) was associated with a significantly lower rate of any atrial arrhythmia recurrence (25.5%) compared to late DAT (>12 months) (52.0%) (p=0.003).
  • Delayed catheter ablation (>12 months) was an independent predictor of arrhythmia recurrence (OR: 2.58; 95% CI: 1.32-5.07).

Conclusions:

  • Early first-time catheter ablation (DAT ≤12 months) in younger patients (≤55 years) with persistent AF is linked to significantly lower arrhythmia recurrence rates.
  • Timely intervention may improve long-term outcomes for persistent AF in this demographic.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
909
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1